Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442)
| 針對症狀 | Metastatic Androgen Independent Prostate Cancer |
| 臨床試驗編號 | NCT00849290 |
| 臨床階段 | Phase II |
| 臨床試驗位址 | 58 Study Locations |
| 目前研究進度 | This study has been completed. |
| 試驗開始日期 | February 19, 2009 |
| 試驗開始日期 | October 8, 2010 |
| 臨床目的 |
This is an open label, Phase 2 trial of APC8015F immunotherapy in men with objective disease progression on protocol D9902 part B (NCT00065442) http://clinicaltrials.gov/ct2/show/study/NCT00849290?term=dendreon&rank=8&show_locs=Y#locn#locn |